Nephro Care India Limited is an India-based company that operates as a healthcare provider. Its business is to provide a comprehensive 360-degree healthcare service to patients with kidney-related services. It operates only in non-invasive service. It offers a range of clinical and lifestyle solutions and services and renal insufficiency treatment for patients. Its treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. It provides holistic care for renal failure patients, which includes consultation, treatment, and yoga. It offers nutritional support for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, Lupus nephropathy, and ADPKD. It operates various clinics, such as Renal Transplant, Urology, and Vascular Surgery. It also offers other services, such as Pulmonary function test, EMG/NCV-testing, Uroflowmetry, EEG, Polysomnography, and others.As of 31 May 2026, NEPHRO CARE INDIA LIMITED share price is ₹76.25. The stock opened at ₹77.00, compared to its previous close of ₹80.25. During today's trading session, NEPHRO CARE INDIA LIMITED share price moved in the range of ₹76.25 to ₹77.00, with an average price of ₹76.63 for the day. Looking at its last 52-week, the stock has touched a low of ₹76.25 and a high of ₹77.00. On the performance front, NEPHRO CARE INDIA LIMITED share price has declined by 44.16% over the last six months and is down 43.56% on a year-on-year basis.
The market capitalization of NEPHRO CARE INDIA LIMITED is ₹126 Crs, with a P/E ratio of 34.5 and a dividend yield of 0.00%.